Lumos Pharma Stock Forecast - Daily Balance Of Power
| LUMO Stock | USD 4.30 0.02 0.46% |
Lumos Stock Forecast is based on your current time horizon. Although Lumos Pharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Lumos Pharma's systematic risk associated with finding meaningful patterns of Lumos Pharma fundamentals over time.
Lumos |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.7647 | (0.12) |
| Check Lumos Pharma Volatility | Backtest Lumos Pharma | Trend Details |
Lumos Pharma Trading Date Momentum
| On May 03 2024 Lumos Pharma was traded for 2.96 at the closing time. The top price for the day was 3.05 and the lowest listed price was 2.90 . The trading volume for the day was 69.6 K. The trading history from May 3, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.63% . The trading delta at closing time against the current closing price is 2.63% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Lumos Pharma to competition |
Other Forecasting Options for Lumos Pharma
For every potential investor in Lumos, whether a beginner or expert, Lumos Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lumos Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lumos. Basic forecasting techniques help filter out the noise by identifying Lumos Pharma's price trends.Lumos Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lumos Pharma stock to make a market-neutral strategy. Peer analysis of Lumos Pharma could also be used in its relative valuation, which is a method of valuing Lumos Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lumos Pharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Lumos Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Lumos Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Lumos Pharma Market Strength Events
Market strength indicators help investors to evaluate how Lumos Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lumos Pharma shares will generate the highest return on investment. By undertsting and applying Lumos Pharma stock market strength indicators, traders can identify Lumos Pharma entry and exit signals to maximize returns.
Lumos Pharma Risk Indicators
The analysis of Lumos Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lumos Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lumos stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.35 | |||
| Semi Deviation | 2.95 | |||
| Standard Deviation | 3.36 | |||
| Variance | 11.32 | |||
| Downside Variance | 9.46 | |||
| Semi Variance | 8.67 | |||
| Expected Short fall | (2.63) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Lumos Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lumos Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lumos Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lumos Pharma Stock: Check out Historical Fundamental Analysis of Lumos Pharma to cross-verify your projections. To learn how to invest in Lumos Stock, please use our How to Invest in Lumos Pharma guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lumos Pharma. If investors know Lumos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lumos Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 0.27 | Quarterly Revenue Growth 102.714 | Return On Assets (0.70) | Return On Equity (1.73) |
The market value of Lumos Pharma is measured differently than its book value, which is the value of Lumos that is recorded on the company's balance sheet. Investors also form their own opinion of Lumos Pharma's value that differs from its market value or its book value, called intrinsic value, which is Lumos Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lumos Pharma's market value can be influenced by many factors that don't directly affect Lumos Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lumos Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lumos Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lumos Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.